Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan
Radiology
.
2017 Jul;284(1):301-303.
doi: 10.1148/radiol.2017170252.
Authors
Shunji Mugikura
1
,
Miki Fujimura
2
,
Shoki Takahashi
1
,
Kei Takase
1
Affiliations
1
Departments of Diagnostic Radiology * and.
2
Neurosurgery, † Graduate School of Medicine, Tohoku University, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.
PMID:
28628405
DOI:
10.1148/radiol.2017170252
No abstract available
Publication types
Comment
MeSH terms
Acetazolamide*
Cerebrovascular Circulation
Humans
Japan
Moyamoya Disease*
Off-Label Use
Substances
Acetazolamide